TEP1
Basic information
Region (hg38): 14:20365667-20413501
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TEP1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 7 | |||||
missense | 168 | 17 | 10 | 195 | ||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 168 | 20 | 15 |
Variants in TEP1
This is a list of pathogenic ClinVar variants found in the TEP1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-20368456-T-A | not specified | Uncertain significance (Dec 08, 2023) | ||
14-20368478-C-T | not specified | Uncertain significance (Oct 30, 2023) | ||
14-20368507-C-T | not specified | Uncertain significance (Sep 22, 2023) | ||
14-20368542-G-A | Likely benign (Dec 01, 2022) | |||
14-20368557-C-T | Benign (Apr 04, 2018) | |||
14-20368812-G-T | not specified | Uncertain significance (May 16, 2023) | ||
14-20368878-G-A | not specified | Uncertain significance (Nov 07, 2023) | ||
14-20368894-C-T | Benign (Nov 20, 2018) | |||
14-20369429-C-A | not specified | Uncertain significance (Dec 13, 2022) | ||
14-20369465-G-A | not specified | Uncertain significance (Sep 19, 2022) | ||
14-20369504-C-A | not specified | Uncertain significance (May 07, 2024) | ||
14-20369508-C-T | not specified | Uncertain significance (Oct 25, 2023) | ||
14-20369542-G-C | Benign (Jul 15, 2020) | |||
14-20369561-C-G | not specified | Uncertain significance (Nov 18, 2022) | ||
14-20369576-T-C | not specified | Uncertain significance (Dec 28, 2023) | ||
14-20369700-G-A | not specified | Uncertain significance (Jan 29, 2024) | ||
14-20369718-G-A | not specified | Uncertain significance (Feb 10, 2022) | ||
14-20371290-C-T | not specified | Uncertain significance (Sep 01, 2021) | ||
14-20371618-C-T | not specified | Uncertain significance (Jul 06, 2021) | ||
14-20371622-T-C | not specified | Uncertain significance (Aug 04, 2023) | ||
14-20372751-G-A | not specified | Uncertain significance (Jun 22, 2021) | ||
14-20372761-G-A | not specified | Uncertain significance (Oct 26, 2022) | ||
14-20372772-T-C | Likely benign (Oct 05, 2017) | |||
14-20373037-C-T | not specified | Uncertain significance (Dec 12, 2023) | ||
14-20373117-G-A | not specified | Uncertain significance (May 27, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TEP1 | protein_coding | protein_coding | ENST00000262715 | 54 | 47763 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.38e-49 | 0.411 | 125265 | 4 | 479 | 125748 | 0.00192 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0789 | 1470 | 1.48e+3 | 0.994 | 0.0000875 | 16837 |
Missense in Polyphen | 434 | 460.08 | 0.94331 | 5489 | ||
Synonymous | 1.05 | 563 | 596 | 0.945 | 0.0000333 | 5546 |
Loss of Function | 3.18 | 98 | 138 | 0.709 | 0.00000724 | 1485 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00550 | 0.00543 |
Ashkenazi Jewish | 0.000398 | 0.000397 |
East Asian | 0.00401 | 0.00354 |
Finnish | 0.000187 | 0.000185 |
European (Non-Finnish) | 0.00136 | 0.00135 |
Middle Eastern | 0.00401 | 0.00354 |
South Asian | 0.00399 | 0.00389 |
Other | 0.00134 | 0.00130 |
dbNSFP
Source:
- Function
- FUNCTION: Component of the telomerase ribonucleoprotein complex that is essential for the replication of chromosome termini (PubMed:19179534). Also component of the ribonucleoprotein vaults particle, a multi-subunit structure involved in nucleo-cytoplasmic transport (By similarity). Responsible for the localizing and stabilizing vault RNA (vRNA) association in the vault ribonucleoprotein particle. Binds to TERC (By similarity). {ECO:0000250|UniProtKB:P97499, ECO:0000269|PubMed:19179534}.;
- Pathway
- telomeres telomerase cellular aging and immortality
(Consensus)
Recessive Scores
- pRec
- 0.0972
Intolerance Scores
- loftool
- 0.920
- rvis_EVS
- 4.19
- rvis_percentile_EVS
- 99.71
Haploinsufficiency Scores
- pHI
- 0.210
- hipred
- N
- hipred_score
- 0.332
- ghis
- 0.430
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.343
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Tep1
- Phenotype
- growth/size/body region phenotype; homeostasis/metabolism phenotype; normal phenotype; skeleton phenotype;
Gene ontology
- Biological process
- telomere maintenance via recombination;RNA-dependent DNA biosynthetic process
- Cellular component
- chromosome, telomeric region;telomerase holoenzyme complex;cytoplasm;nuclear matrix;ribonucleoprotein complex
- Molecular function
- p53 binding;telomerase activity;RNA binding;ATP binding;enzyme binding;telomerase RNA binding